Literature DB >> 8521150

Resistance to aging-associated obesity in capsaicin-desensitized rats one year after treatment.

A Melnyk1, J Himms-Hagen.   

Abstract

Previous studies demonstrated reduced weight of abdominal white adipose tissue depots and of carcass fat in capsaicin-desensitized (Cap-Des) rats up to 8 months after treatment. The objective of the present study was to find out whether aging-associated obesity and hyperplasia of retroperitoneal white adipose tissue was prevented in older (13.5 months old) Cap-Des rats, one year after treatment with Cap (done when they were 1.5 months old). The prevalence of obesity is known to increase in rats by this age. Abdominal white adipose tissue depots weighed less in old Cap-Des rats, both epididymal (9% less) and retroperitoneal (30% less). The number of mature white adipocytes was 28% less in the retroperitoneal depot but was not significantly different in the epididymal depot. Adipocyte size was not different. Carcass fat was less, both total and as percent of body weight. Food intake was normal for their reduced body size. The exponential increase in retroperitoneal white adipose tissue weight characteristic of aging rats that are becoming obese was virtually absent in Cap-Des rats. We conclude that lack of function of capsaicin-sensitive afferent autonomic nerves, known to be destroyed in Cap-Des rats, results in an alteration in energy balance conducive to leanness. We suggest that the attenuated age-associated increase in circulating CGRP (derived mainly from capsaicin-sensitive nerves) in the Cap-Des rat results in a lower degree of aging-associated insulin-resistance, hence in a lesser degree of obesity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8521150     DOI: 10.1002/j.1550-8528.1995.tb00159.x

Source DB:  PubMed          Journal:  Obes Res        ISSN: 1071-7323


  23 in total

1.  Treating diet-induced obesity: a new role for vagal afferents?

Authors:  Edward A Fox
Journal:  Dig Dis Sci       Date:  2012-03-22       Impact factor: 3.199

2.  Determination of body fat distribution by dual-energy X-ray absorptiometry and attenuation of visceral fat vasoconstriction by enalapril.

Authors:  Felix W Leung; Samuel Murray; Elsa Murray; Vay Liang Go
Journal:  Dig Dis Sci       Date:  2007-10-16       Impact factor: 3.199

Review 3.  Crosstalk between the nociceptive and immune systems in host defence and disease.

Authors:  Stephen B McMahon; Federica La Russa; David L H Bennett
Journal:  Nat Rev Neurosci       Date:  2015-07       Impact factor: 34.870

Review 4.  Relations between metabolic homeostasis, diet, and peripheral afferent neuron biology.

Authors:  Tamara N Dunn; Sean H Adams
Journal:  Adv Nutr       Date:  2014-07-14       Impact factor: 8.701

5.  Relative contributions of afferent vagal fibers to resistance to diet-induced obesity.

Authors:  A T Stearns; A Balakrishnan; A Radmanesh; S W Ashley; D B Rhoads; A Tavakkolizadeh
Journal:  Dig Dis Sci       Date:  2011-12-03       Impact factor: 3.199

Review 6.  TRP channels and their implications in metabolic diseases.

Authors:  Zhiming Zhu; Zhidan Luo; Shuangtao Ma; Daoyan Liu
Journal:  Pflugers Arch       Date:  2010-11-26       Impact factor: 3.657

Review 7.  Vagal afferent controls of feeding: a possible role for gastrointestinal BDNF.

Authors:  Edward A Fox
Journal:  Clin Auton Res       Date:  2012-06-21       Impact factor: 4.435

Review 8.  Vanilloid receptors--do they have a role in whole body metabolism? Evidence from TRPV1.

Authors:  Andrea Zsombok
Journal:  J Diabetes Complications       Date:  2013-01-16       Impact factor: 2.852

9.  Pilot studies to demonstrate that intestinal mucosal afferent nerves are functionally linked to visceral adipose tissue.

Authors:  Felix W Leung; Vay Liang W Go; Oscar U Scremin; Andre Obenaus; Michael L Tuck; Michael S Golub; Peter Eggena; Joseph W Leung
Journal:  Dig Dis Sci       Date:  2007-03-28       Impact factor: 3.199

10.  TRPV1-null mice are protected from diet-induced obesity.

Authors:  Arianne L Motter; Gerard P Ahern
Journal:  FEBS Lett       Date:  2008-05-27       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.